Sinocelltech Group Stock Net Asset

688520 Stock   37.21  0.79  2.08%   
Sinocelltech Group fundamentals help investors to digest information that contributes to Sinocelltech's financial success or failures. It also enables traders to predict the movement of Sinocelltech Stock. The fundamental analysis module provides a way to measure Sinocelltech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sinocelltech stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Sinocelltech Group Company Net Asset Analysis

Sinocelltech's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Net Asset

 = 

Current Market Value

-

Current Liabilities

More About Net Asset | All Equity Analysis

Current Sinocelltech Net Asset

    
  2.72 B  
Most of Sinocelltech's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sinocelltech Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition

Sinocelltech Total Assets

Total Assets

2.05 Billion

At present, Sinocelltech's Total Assets are projected to increase significantly based on the last few years of reporting.
Based on the recorded statements, Sinocelltech Group has a Net Asset of 2.72 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all China stocks is notably lower than that of the firm.

Sinocelltech Net Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sinocelltech's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sinocelltech could also be used in its relative valuation, which is a method of valuing Sinocelltech by comparing valuation metrics of similar companies.
Sinocelltech is currently under evaluation in net asset category among its peers.

Sinocelltech Fundamentals

About Sinocelltech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Sinocelltech Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sinocelltech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sinocelltech Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Sinocelltech Stock

Sinocelltech financial ratios help investors to determine whether Sinocelltech Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sinocelltech with respect to the benefits of owning Sinocelltech security.